PubRank

U Grohmann

Author PubWeight™ 22.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002 3.07
2 Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 1992 2.37
3 Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994 1.72
4 Hemisection and vital treatment of a fused tooth--literature review and case report. Endod Dent Traumatol 1997 1.44
5 Gamma interferon modifies CD4+ subset expression in murine candidiasis. Infect Immun 1992 1.19
6 Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. Curr Drug Metab 2007 1.10
7 Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells. J Infect Dis 1992 1.07
8 Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death. Blood 1998 1.02
9 Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions. Curr Med Chem 2011 0.97
10 Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo. J Immunol 2000 0.94
11 Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation. J Immunol 1999 0.88
12 Intraindividual comparative animal study of alpha- and beta-tricalcium phosphate degradation in conjunction with simultaneous insertion of dental implants. J Craniofac Surg 2001 0.88
13 Increase of natural killer activity of mouse lymphocytes following in vitro and in vivo treatment with lithium. Immunopharmacol Immunotoxicol 1988 0.79
14 Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity. Eur J Immunol 1994 0.79
15 Hydroxyurea induces the gene expression and synthesis of proinflammatory cytokines in vivo. J Pharmacol Exp Ther 1997 0.79
16 Dacarbazine-induced immunogenicity of a murine leukemia is attenuated in cells transfected with mutated K-ras gene. J Exp Clin Cancer Res 1997 0.79
17 IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells. J Immunol 1996 0.78
18 Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice. Cell Immunol 1993 0.78
19 Dual effect of IL-4 on resistance to systemic gram-negative infection and production of TNF-alpha. Cytokine 2000 0.77
20 The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. J Chemother 1998 0.77
21 A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. Int J Immunopharmacol 1996 0.75
22 Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells. Int J Immunopharmacol 1990 0.75
23 Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. Int J Immunopharmacol 1992 0.75
24 O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia. Cancer Res 1995 0.75
25 Introduction of "vario plates" for retention after mandibular distraction osteogenesis. Int J Adult Orthodon Orthognath Surg 2000 0.75
26 Genomic aspects of drug-induced xenogenization of murine tumors. Pharmacol Res 1992 0.75
27 Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. Int J Immunopharmacol 1989 0.75
28 Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. Cell Immunol 1988 0.75
29 T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. Int J Cancer 1990 0.75
30 Molecular and genomic aspects of xenogenizing-alkylating drugs. Pharmacol Res 1992 0.75
31 Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens. Cancer Immunol Immunother 1988 0.75
32 [Ophthalmological requirements of the applicants for the Bundesmarine]. Klin Monbl Augenheilkd 1967 0.75
33 Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. Eur J Pharmacol 1996 0.75
34 [On the problem of visual field reduction due to acoustic trauma]. Klin Monbl Augenheilkd 1968 0.75
35 Cytokines and tumours: problems and perspectives. Pharmacol Res 1994 0.75
36 Loss of growth arrest DNA damage genes expression in oral melanomas. In Vivo 2000 0.75
37 Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes. Int J Immunopharmacol 1994 0.75
38 Antagonistic effect of IL-2 on DTIC-induced impairment of tumor-specific cell-mediated immunity in vitro. Pharmacol Res 1992 0.75